74 related articles for article (PubMed ID: 1543548)
1. Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells.
Kemp JD; Smith KM; Mayer JM; Gomez F; Thorson JA; Naumann PW
Pathobiology; 1992; 60(1):27-32. PubMed ID: 1543548
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
Kemp JD; Cardillo T; Stewart BC; Kehrberg E; Weiner G; Hedlund B; Naumann PW
Cancer Res; 1995 Sep; 55(17):3817-24. PubMed ID: 7641199
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
Kemp JD; Smith KM; Kanner LJ; Gomez F; Thorson JA; Naumann PW
Blood; 1990 Sep; 76(5):991-5. PubMed ID: 2393721
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
Kemp JD; Thorson JA; Stewart BC; Naumann PW
Cancer Res; 1992 Aug; 52(15):4144-8. PubMed ID: 1638529
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: a comparison of three reagents and further studies of their range of effects and mechanism of action.
Kemp JD; Thorson JA; Gomez F; Smith KM; Cowdery JS; Ballas ZK
Cell Immunol; 1989 Aug; 122(1):218-30. PubMed ID: 2526689
[TBL] [Abstract][Full Text] [Related]
6. Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.
Kemp JD
Histol Histopathol; 1997 Jan; 12(1):291-6. PubMed ID: 9046063
[TBL] [Abstract][Full Text] [Related]
7. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
8. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
Taetle R; Honeysett JM
Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
[TBL] [Abstract][Full Text] [Related]
9. Differing sensitivity of non-hematopoietic human tumors to synergistic anti-transferrin receptor monoclonal antibodies and deferoxamine in vitro.
Kovar J; Naumann PW; Stewart BC; Kemp JD
Pathobiology; 1995; 63(2):65-70. PubMed ID: 8554701
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
11. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
Brooks D; Taylor C; Dos Santos B; Linden H; Houghton A; Hecht TT; Kornfeld S; Taetle R
Clin Cancer Res; 1995 Nov; 1(11):1259-65. PubMed ID: 9815920
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of the human transferrin receptor: effects of anti-receptor monoclonal antibodies on tumor growth.
Trowbridge IS; Collawn J; Jing S; White S; Esekogwu V; Stangel M
Curr Stud Hematol Blood Transfus; 1991; (58):139-47. PubMed ID: 1954762
[No Abstract] [Full Text] [Related]
13. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
14. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells.
Shen X; Zhu HF; He FR; Xing W; Li L; Liu J; Yang J; Pan XF; Lei P; Wang ZH; Shen GX
Int Immunopharmacol; 2008 Dec; 8(13-14):1813-20. PubMed ID: 18817895
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of transferrin receptors and their relationship to cell growth.
Trowbridge IS; Shackelford DA
Biochem Soc Symp; 1986; 51():117-29. PubMed ID: 3545211
[TBL] [Abstract][Full Text] [Related]
16. Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.
Rodríguez JA; Helguera G; Daniels TR; Neacato II; López-Valdés HE; Charles AC; Penichet ML
J Control Release; 2007 Dec; 124(1-2):35-42. PubMed ID: 17884229
[TBL] [Abstract][Full Text] [Related]
17. Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells.
Hong Y; Yang J; Shen X; Zhu H; Sun X; Wen X; Bian J; Hu H; Yuan L; Tao J; Lei P; Shen G
Cancer Immunol Immunother; 2013 Mar; 62(3):447-54. PubMed ID: 22941037
[TBL] [Abstract][Full Text] [Related]
18. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
Jones DT; Trowbridge IS; Harris AL
Cancer Res; 2006 Mar; 66(5):2749-56. PubMed ID: 16510596
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
Taetle R; Castagnola J; Mendelsohn J
Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptor as a potential therapeutic target.
Trowbridge IS
Prog Allergy; 1988; 45():121-46. PubMed ID: 3064093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
